Client News

Roquefort Therapeutics PLC – Results of AGM
Home / Client News / Roquefort Therapeutics PLC – Results of AGM

Roquefort Therapeutics (LSE:ROQ, OTCQB: ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, is pleased to announce that at the Company’s Annual General Meeting (“AGM”) held earlier today, all resolutions proposed were duly passed.

 

The resolutions were put to shareholders via a poll, the results of which were as follows:

Resolution

Poll Results

Total Votes Withheld*

For

Against

Total Votes Cast

1

Shares

21,890,925

21,890,925

%

100.00%

2

Shares

21,890,885

20

21,890,905

20

%

100.00%

0.00%

3

Shares

21,890,885

20

21,890,905

20

%

100.00%

0.00%

4

Shares

10,257,712

2,713

10,260,425

11,630,500

%

99.97%

0.03%

5

Shares

21,890,925

21,890,925

%

100.00%

6

Shares

21,890,885

20

21,890,905

20

%

100.00%

0.00%

7

Shares

21,890,925

21,890,925

%

100.00%

8

Shares

21,890,905

20

21,890,925

%

100.00%

0.00%

9

Shares

21,885,885

20

21,885,905

5,020

%

100.00%

0.00%

10

Shares

21,855,276

35,629

21,890,905

20

%

99.84%

0.16%

11

Shares

21,885,071

573

21,885,644

5,281

%

100.00%

0.00%

* Votes withheld are not counted in the calculation of the proportion of votes for and against a resolution.

 

Results of AGM – 10:05:01 29 Jun 2023 – ROQ News article | London Stock Exchange

OPEN AN ACCOUNT

If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.

CLIENT AREA

Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This